Recombinant Human fabG Protein，His

FabG, also known as β-ketoacyl-ACP reductase, is an essential enzyme in the fatty acid biosynthesis pathway, catalyzing the reduction of β-ketoacyl acyl carrier protein (ACP) to yield acyl-ACP. This reaction is a critical step in the metabolic pathway that synthesizes fatty acids, which are vital components of cellular membranes and energy storage molecules. Understanding the structure and function of FabG is pivotal, as it offers insights into the regulatory mechanisms of fatty acid metabolism and can inform the development of antibiotics, given that fatty acid biosynthesis is a prime target in bacterial pathogens. The research on recombinant FabG proteins involves the molecular cloning and expression of the fabG gene in various host systems, often leading to the production of the enzyme in substantial quantities for further characterization. These studies aim to elucidate the enzyme's kinetic properties, substrate specificity, and structural features using techniques such as X-ray crystallography and NMR spectroscopy. Moreover, recombinant FabG can be used in metabolic engineering applications to enhance fatty acid production in microbial hosts, thus contributing to biofuel and biodegradable polymer industries. The recent advancements in synthetic biology and protein engineering have further opened avenues for modulating FabG activity and stability, thereby enhancing our understanding of its role in metabolic pathways and its potential industrial applications.